About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Metformin can Now Prevent Heart Disease in Type 1 Diabetes
Advertisement

Metformin can Now Prevent Heart Disease in Type 1 Diabetes

Font : A-A+

Highlights:
  • Heart disease can be prevented in Type 1 diabetes by using the drug metformin
  • Metformin is a cheap and effective drug used for Type 2 diabetes, but generally not used for Type 1 diabetes
  • Metformin helps the body to repair damaged blood vessels by modulating the levels of microRNA molecules such as miR-222, miR-195 and miR-21a
  • Modulation of the levels of microRNAs could lead to the development of better treatment and prevention strategies for delaying the onset of heart disease in Type 1 diabetic patients

Heart disease can be prevented in Type 1 diabetic patients using a novel strategy, a new study suggests. Scientists at the Institute of Cellular Medicine, Newcastle University, UK, have elucidated the molecular mechanism how a commonly prescribed drug for Type 2 diabetes can prevent heart disease in Type 1 diabetic patients. The study was published in the International Journal of Molecular Sciences.

Metformin is a cheap and effective drug used for treating Type 2 diabetes. It is not generally used for treating Type 1 diabetes, but the present clinical trial has indicated that metformin could prevent heart disease in Type 1 diabetic patients. The researchers at Newcastle University have discovered the underlying mechanism involved.

Advertisement

Metformin can Now Prevent Heart Disease in Type 1 Diabetes

The present study found that metformin not only controlled blood sugar levels, but also helped repair damaged blood vessels by lowering microRNA (miR) levels in the vicinity, in order to stimulate the growth of blood vessels. These miRs are very small RNA (ribonucleic acid) molecules that regulate gene expression in cells. The anti-angiogenic miRNA molecules that were used in the study included miR-222, miR-195, and miR-21a.

The present study is based upon a previous study by the same group, which showed that metformin could improve vascular stem cells, thereby slowing the development of heart disease.
Advertisement

Dr. Jolanta Weaver, Senior Lecturer at the Institute of Cellular Medicine, Newcastle University and Honorary Consultant Diabetologist at the Queen Elizabeth Hospital, Gateshead, Newcastle upon Tyne, UK, led the clinical trial and is the senior author of the study, said: "As the outcomes of heart disease are worse in diabetic patients compared to people who don't have diabetes, there is a need to identify additional treatment options."

Clinical Trial Design

This clinical trial, dubbed as the MERIT Study, is the first study to evaluate the efficacy of metformin in preventing heart disease in Type 1 diabetic patients. This was an open-label, case-controlled study, which consisted of the following groups:
  • Group 1: The first group (intervention group) included 23 Type 1 diabetic patients, 19-65 years of age, who did not have any signs of heart disease. This group was treated with metformin for 2 months.
  • Group 2: The second group consisted of 9 age and sex-matched Type 1 diabetic patients who were on insulin therapy.
  • Group 3: The third group consisted of 23 healthy volunteers who did not have Type 1 diabetes.

Clinical Trial Findings

  • The levels of the microRNAs miR-222, miR-195 and miR-21a were initially found to be higher in the Type 1 diabetes group than in the control group.
  • Treatment with metformin reduced the levels of miR-222, miR-195 and miR-21a significantly.
  • The fall in the levels of miR-222 was accompanied by a decrease in the levels of circulating endothelial cells.
  • The above observation is indicative of the improvement in the vascular repair process.

Expert Comments

Dr. Weaver said: "These results confirm that as well as improving a patient's blood sugar control, metformin is working to protect the heart."

She adds: "This is an exciting development as understanding this underlying mechanism opens up the possibility of new forms of treatment which will lower the chances of patients with Type 1 diabetes developing heart disease."

Future Plans

The research team's future goals will focus on the development of therapeutic strategies by targeting miRs in order to modulate their function.

Reference :
  1. Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study - (https://doi.org/10.3390/ijms19103242)


Source: Medindia

Citations   close

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dr. Kaushik Bharati. (2018, October 22). Metformin can Now Prevent Heart Disease in Type 1 Diabetes. Medindia. Retrieved on May 22, 2022 from https://www.medindia.net/news/healthinfocus/metformin-can-now-prevent-heart-disease-in-type-1-diabetes-183232-1.htm.

  • MLA

    Dr. Kaushik Bharati. "Metformin can Now Prevent Heart Disease in Type 1 Diabetes". Medindia. May 22, 2022. <https://www.medindia.net/news/healthinfocus/metformin-can-now-prevent-heart-disease-in-type-1-diabetes-183232-1.htm>.

  • Chicago

    Dr. Kaushik Bharati. "Metformin can Now Prevent Heart Disease in Type 1 Diabetes". Medindia. https://www.medindia.net/news/healthinfocus/metformin-can-now-prevent-heart-disease-in-type-1-diabetes-183232-1.htm. (accessed May 22, 2022).

  • Harvard

    Dr. Kaushik Bharati. 2021. Metformin can Now Prevent Heart Disease in Type 1 Diabetes. Medindia, viewed May 22, 2022, https://www.medindia.net/news/healthinfocus/metformin-can-now-prevent-heart-disease-in-type-1-diabetes-183232-1.htm.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Prevent Hacking of Medical Devices: FDA Sounds Alarm
Black Water: Benefits and Uses
World Hypertension Day 2022 - Measure Blood Pressure Accurately, Control It, Live Longer!
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetic Retinopathy Diabetes Diabetic Diet Otitis Media Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Cardiac Catheterization Diabetes and Exercise Heart Attack 

Most Popular on Medindia

Daily Calorie Requirements Find a Hospital Blood Pressure Calculator The Essence of Yoga Turmeric Powder - Health Benefits, Uses & Side Effects Pregnancy Confirmation Calculator Drug Interaction Checker Nutam (400mg) (Piracetam) Post-Nasal Drip Drug - Food Interactions

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR